Support intensive care research

SGLT2 inhibitors ("flozins") are increasingly prescribed for heart failure and chronic kidney disease, yet there is no consensus on whether to continue or withhold them when patients are admitted to intensive care.

FLO-CRIT is a short, anonymous survey exploring how intensive care clinicians currently manage these medications and their views on the associated uncertainties whether they would support future studies in this area.

We warmly invite consultants, trainees, pharmacists and advanced critical care practitioners to take part.

The survey takes around 5 minutes and will help inform future prospective research.

You are invited to take part in a research project supported by CICM and CERSI-AI.

The aim of this study is to identify and prioritise the most important opportunities for applying artificial intelligence (AI) to the clinical practice of intensive care.

Your responses will help shape a final list of top priorities to guide future research, development and investment in AI across the specialty.

The survey is open to clinical ICU staff (doctors, nurses, ACCPs, AHPs and pharmacists).

RECOVERY-RS was a UK multi-centre randomised controlled trial undertaken in 2020 and 2021 to evaluate the clinical effectiveness of CPAP and HFNO, compared with standard oxygen therapy, in COVID-19 acute hypoxaemic respiratory failure.

Trial results were first shared on 4th August 2021 on the preprint server medRxiv and subsequently published in JAMA in January 2022.

Preprint: https://www.medrxiv.org/content/10.1101/2021.08.02.21261379v1.

JAMA paper: https://jamanetwork.com/journals/jama/fullarticle/2788505

The purpose of this survey is to gather information to support a REF2029 Impact Case Study being submitted by Queen’s University Belfast (incl. Profs. Danny McAuley & Bronwen Connolly) and University of Warwick (incl. Profs. Gavin Perkins & Keith Couper).

This survey is intended for medical colleagues at consultant grade or equivalent with decision-making responsibility for initiation of non-invasive respiratory support. 

We would be grateful for your support in completing this survey to assist with collection of information to support this Impact Case Study

This is your opportunity to be involved in cutting edge research in UK Intensive Care units.

ECHO-MAD is a United Kingdom Service Evaluation Study to assess how echocardiography changes management of patients within intensive care supported by the Intensive Care Society (ICS), Focused Ultrasound in Intensive Care (FUSIC), British Society of Echocardiography (BSE) and the Trainee Research in Intensive Care (TRIC) Network.

Data entry for the study will occur for 2 weeks within a period between 28^th September and 19^th October and there will be a second round of data entry in early 2027. 

Who we are looking for?

UK based Intensive Resident Doctors/ AHPs with a keen interest in research and echocardiography. 

Roles available: 

Regional Leads- To take the lead in their region and getting hospitals within it involved and active

Site leads: To lead their hospital in gathering data and assisting with data entry

Local investigators: To perform or review echocardiograms and enter data into the REDCap online system. 

What will be required: 

A short questionnaire following any echocardiograms performed on your Intensive Care Unit entered into an online database. Each entry should take between 3-4 minutes.

Whats in it for you?:

All regional leads and collaborators will be recognised in any future publications.

Local investigators will be able to use proof of involvement in the project to link to HiLOs in the Stage1/2/3 curriculum of both ICM and Anaesthetics.

How you can get involved?:

You can email echomadstudy@gmail.com with an expression of interest and we will be in touch with the protocol and how to get started.  

Study Organisers

Dr Prashant Parulekar, Consultant in Critical Care - Chief investigator and Dr Dan Sumner, Specialist Trainee in Critical Care and Anaesthesia- Associate Chief investigator